AR and prostate carcinoma: In prostate cancer, GAS5 functions by inducing apoptosis and repressing androgen receptor (AR) activity, sequestering the androgen/AR complex and inhibiting the AR signaling pathway, which is vital for prostate cancer cell survival and growth (74, 75).